Business Context and Reporting Period
Bowhead Specialty Holdings Inc. (BOW) filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024. The Company is a specialty property and casualty insurance holding company operating primarily in the U.S. through three wholly-owned subsidiaries. It focuses on Casualty, Professional Liability, and Healthcare Liability risks, primarily written on an excess and surplus (E&S) basis. The Company operates as a single segment and maintains a strategic partnership with American Family Mutual Insurance Company (AmFam), which owns approximately 18.6% of the Company's common stock. The Company completed its Initial Public Offering (IPO) in May 2024.
Key Financial Metrics
| Metric ($ in thousands) | Three Months Ended Sept 30, 2024 | Nine Months Ended Sept 30, 2024 | Sept 30, 2024 Balance Sheet |
|---|---|---|---|
| Gross Written Premiums | $196,976 | $510,948 | - |
| Net Written Premiums | $128,333 | $331,238 | - |
| Net Earned Premiums | $105,180 | $278,247 | - |
| Net Investment Income | $11,491 | $27,928 | - |
| Total Revenues | $116,761 | $306,330 | - |
| Net Income | $12,092 | $24,637 | - |
| Loss Ratio | 64.5% | 65.1% | - |
| Combined Ratio | 94.4% | 97.0% | - |
| Total Assets | - | - | $1,547,662 |
| Total Liabilities | - | - | $1,182,836 |
| Stockholders' Equity | - | - | $364,671 |
| Cash & Cash Equivalents | - | - | $132,893 |
| Restricted Cash | - | - | $28,822 |
Debt and Liquidity: The Company has a $75 million senior secured revolving credit facility with no borrowings outstanding as of September 30, 2024. Total cash, cash equivalents, and restricted cash were $161.7 million.
Material Changes vs. Prior Period
- Premium Growth: Gross written premiums increased 32.3% quarter-over-quarter (QoQ) and 41.4% year-over-year (YoY) for the nine-month period, driven by renewals, new business, and a large audit premium.
- Profitability: Net income increased 38.9% QoQ to $12.1 million and 21.6% YoY to $24.6 million for the nine-month period.
- Underwriting Ratios: The loss ratio increased to 64.5% (Q3) and 65.1% (9M) compared to 60.4% and 60.5% in the prior year periods, respectively. This increase is attributed to a higher proportion of Casualty business, which carries higher industry loss ratios. The expense ratio improved slightly to 29.9% (Q3) and 31.9% (9M).
- Investment Income: Net investment income more than doubled QoQ (121.5% increase) and YoY (121.8% increase for 9M), driven by higher average investment balances (including IPO proceeds) and higher yields.
- Capital Structure: Stockholders' equity increased significantly from $192.1 million at year-end 2023 to $364.7 million, primarily due to $131.0 million in net proceeds from the May 2024 IPO and capital contributions.
Guidance, Outlook, and Risks
- Outlook: Management expects to continue growing the business profitably, leveraging its strategic relationship with AmFam. The Company is focused on maintaining underwriting discipline and managing capital prudently.
- Unusual Items: The Company incurred non-operating expenses of $2.2 million for the nine months ended September 30, 2024, related to the IPO. Additionally, $1.3 million of stock-based compensation costs associated with Class P interests were accelerated in Q2 2024.
- Key Risks:
- AmFam Dependency: The Company relies heavily on its strategic partnership with AmFam for its MGA agreements and quota share reinsurance. Termination of this relationship would materially adversely affect operations.
- Reserve Adequacy: As with all insurers, there is a risk that loss reserves may be inadequate to cover actual losses, particularly given the Company's limited operating history and reliance on industry data for certain lines.
- Reinsurance Concentration: While reinsurers are highly rated (A or better), the Company faces credit risk if reinsurers fail to reimburse claims. Top five reinsurers account for approximately 91% of reinsurance recoverables.
- Regulatory Capital: The Company must maintain specific surplus and risk-based capital levels under Wisconsin law and a specific stipulation order.
Investor Verification Checklist
- AmFam Relationship Status: Verify the stability and terms of the MGA and Quota Share agreements with AmFam, as this is the core of the business model.
- Loss Development: Monitor future quarters for loss development trends, particularly in the Casualty line, which drove the increase in the loss ratio.
- Reinsurance Renewals: Confirm the renewal terms of reinsurance treaties, specifically the Cyber quota share treaty renewing January 1, 2025, and the general treaties renewing May 1, 2024.
- Capital Deployment: Track how the $131 million in IPO proceeds are being deployed into the investment portfolio and whether the yield on new investments meets expectations.
- Regulatory Compliance: Ensure continued compliance with Wisconsin OCI stipulations regarding surplus and risk-based capital ratios.